The role of reactive oxygen species in morphine addiction of SH-SY5Y cells

Life Sciences

Volumn 124, Issue , 2015, Pages 128-135

  Ma, Jun ^a,b   Yuan, Xuan ^c   Qu, Hengyi ^a   Zhang, Juan ^c   Wang, Dong ^d   Sun, Xiling ^a   Zheng, Qiusheng ^a,b  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b YANTAI UNIVERSITY   (China)

^c SHIHEZI UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Morphine addiction; Reactive oxygen species (ROS); Opioid receptor (MOR)

Indexed keywords

LACTATE DEHYDROGENASE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NITROBLUE TETRAZOLIUM; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; ANTIOXIDANT; CYCLIC AMP; MESSENGER RNA; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MORPHINE ADDICTION; NERVE CELL; NEUROBLASTOMA CELL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNTHESIS; UPREGULATION; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; NEUROBLASTOMA; PATHOPHYSIOLOGY; TIME; TUMOR CELL LINE;

ANALGESICS, OPIOID; ANTIOXIDANTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NEUROBLASTOMA; REACTIVE OXYGEN SPECIES; RECEPTORS, OPIOID, MU; RNA, MESSENGER; TIME FACTORS; TRETINOIN;

EID: 84923323013     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.01.003     Document Type: Article

References (42)

1. C.E. Argoff Recent management advances in acute postoperative pain Pain Pract. 14 5 2014 477 487
2. L.M. Bohn, R.R. Gainetdinov, F.T. Lin, R.J. Lefkowitz, and M.G. Caron Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence Nature 408 6813 2000 720 723
3. F.J. Mohd, F.S. Mohd, M.L. Tan, I.M. Mohamed, and I.A. Mohd The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK-N-SH neuroblastoma cell J. Ethnopharmacol. 148 2013 135 143
4. H. Zhao, H.H. Loh, and P.Y. Law Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization Mol. Pharmacol. 69 4 2006 1421 1432
5. E.V. Varga, M.K. Rubenzik, D. Stropova, M. Sugiyama, V. Grife, and V.J. Hruby Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment J. Pharmacol. Exp. Ther. 306 1 2003 109 115
6. G. Yu, H. Yan, and Z.H. Gong Differential effects of acute and repeated morphine treatment on κ-opioid receptor mRNA levels in mesocorticolimbic system Pharmacol. Rep. 64 2012 445 448
7. F.F. Caputi, F. Lattanzio, D. Carretta, D. Mercatelli, S. Candeletti, and P. Romualdi Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells J. Mol. Neurosci. 51 2 2013 532 538
8. P.N. Hsiao, M.C. Chang, W.F. Cheng, C.A. Chen, H.W. Lin, and C.Y. Hsieh Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways Toxicology 256 2009 83 91
9. A.C. Berger, and J.L. Whistler How to design an opioid drug that causes reduced tolerance and dependence Ann. Neurol. 67 5 2010 559 569
10. P. Kovacic, and A.L. Cooksy Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species Med. Hypotheses 64 2 2005 357 366
11. J.R. Rozisky, G. Laste, I.C. de Macedo, V.S. Santos, R. Krolow, and C. Noschang Neonatal morphine administration leads to changes in hippocampal BDNF levels and antioxidant enzyme activity in the adult life of rats Neurochem. Res. 38 3 2013 494 503
12. D. Jantas, M. Pytel, J.W. Mozrzymas, M. Leskiewicz, M. Regulska, and L. Antkiewicz-Michaluk The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells Neurochem. Int. 52 4-5 2008 864 877
13. D. Li, Z. Wang, H. Chen, J. Wang, Q. Zheng, and J. Shang Isoliquiritigenin induces monocytic differentiation of HL-60 cells Free Radic. Biol. Med. 46 6 2009 731 736
14. 2-induced MIN6N8a cell death Eur. J. Pharmacol. 547 1-3 2006 1 9
15. H. Ammer, and R. Schulz Morphine dependence in human neuroblastoma SH-SY5Y cells is associated with adaptive changes in both the quantity and functional interaction of PGE, receptors and stimulatory G proteins Brain Res. 707 2 1996 235 244
16. T. Avidor-Reiss, M. Bayewitch, R. Levy, N. Matus-Leibovitch, I. Nevo, and Z. Vogel Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment J. Biol. Chem. 270 50 1995 29732 29738
17. S.K. Sharma, W.A. Klee, and M. Nirenberg Opiate-dependent modulation of adenylate cyclase Proc. Natl. Acad. Sci. U. S. A. 74 8 1977 3365 3369
18. D. Wen, C.L. Ma, Y.J. Zhang, Y.X. Meng, Z.Y. Ni, and S.J. Li Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence BMC Neurosci. 13 2012 63
19. F. Zeidán-Chuliá, D.P. Gelain, E.A. Kolling, J.L. Rybarczyk-Filho, P. Ambrosi, and S.R. Terra Major components of energy drinks (caffeine, taurine, and guarana) exert cytotoxic effects on human neuronal SH-SY5Y cells by decreasing reactive oxygen species production Oxidative Med. Cell. Longev. 791795 2013
20. M. Les̈kiewicz, M. Regulska, B. Budziszewska, D. Jantas, L. Jaworska-Feil, and A. Basta-Kaim Neurosteroids enhance the viability of staurosporine and doxorubicin treated differentiated human neuroblastoma SH-SY5Y cells Pharmacol. Rep. 60 2008 686 691
21. O. Tunc, J. Thompson, and K. Tremellen Development of the NBT assay as a marker of sperm oxidative stress Int. J. Androl. 33 1 2010 13 21
22. C.L. Wallington, D.M. Peters, C.R. Gelb, and R.A. Peterfreund Orphanin FQ/nociceptin and mu-opioid receptor mRNA levels in human SH-SY5Y neuroblastoma cells: effects of activating the cAMP-PKA signal transduction pathway Brain Res. 944 1-2 2002 73 81
23. C.P. LeBel, S.F. Ali, M. McKee, and S.C. Bondy Organometal-induced increases in oxygen reactive species: the potential of 2′,7′-dichlorofluorescin diacetate as an index of neurotoxic damage Toxicol. Appl. Pharmacol. 104 1 1990 17 24
24. X. Lin, Y.J. Wang, Q. Li, Y.Y. Hou, M.H. Hong, and Y.L. Cao Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway FEBS J. 276 7 2009 2022 2036
25. F. Fang, Q. Wang, Q. Cao, and J. Liu Changes of AC/cAMP system and phosphorylation regulation of adenylate cyclase activity in brain regions from morphine-dependent mice Zhongguo Yi Xue Ke Xue Yuan Xue Bao 22 1 2000 14 19
26. H. Shijun, Z. Liping, Q. Yongqiang, L. Zhen, Z. Yonghe, and L. Lihua Morphine-induced changes of adenylate and guanylate cyclase in locus ceruleus, periaqueductal gray, and substantia nigra in rats Am. J. Drug Alcohol Abuse 35 3 2009 133 137
27. M.J. Christie Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction Br. J. Pharmacol. 154 2 2008 384 396
28. J. Zhang, S.S. Ferguson, L.S. Barak, S.R. Bodduluri, S.A. Laporte, and P.Y. Law Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness Proc. Natl. Acad. Sci. U. S. A. 95 12 1998 7157 7162
29. J. Pan, Q. Zhang, Y. Zhang, Z. Ouyang, Q. Zheng, and R. Zheng Oxidative stress in heroin administered mice and natural antioxidants protection Life Sci. 77 2 2005 183 193
30. H.R. Xie, L.S. Hu, and G.Y. Li SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease Chin. Med. J. 123 8 2010 1086 1092
31. J.M. Gutteridge, and B. Halliwell Free radicals and antioxidants in the year 2000. A historical look to the future Ann. N. Y. Acad. Sci. 899 2000 136 147
32. M. Xia, V. Guo, R. Huang, S.A. Shahane, C.P. Austin, and M. Nirenberg Inhibition of morphine-induced cAMP overshoot: a cell-based assay model in a high-throughput format Cell. Mol. Neurobiol. 31 6 2011 901 907
33. J.T. Williams, S.L. Ingram, G. Henderson, C. Chavkin, M. von Zastrow, and S. Schulz Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance Pharmacol. Rev. 65 1 2013 223 254
34. B. Feng, Z. Li, and J.B. Wang Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling Mol. Pharmacol. 79 4 2011 768 775
35. B. Jiang, Y. Shi, H. Li, L. Kang, and L. Ma Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray Neurosci. Lett. 400 1-2 2006 150 153
36. D. Willner, A. Cohen-Yeshurun, A. Avidan, V. Ozersky, E. Shohami, and R.R. Leker Short term morphine exposure in vitro alters proliferation and differentiation of neural progenitor cells and promotes apoptosis via mu receptors PLoS One 9 7 2014 e103043 (29)
37. V.C. Dang, and M.J. Christie Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons Br. J. Pharmacol. 165 6 2012 1704 1716
38. R.S. Harrison, G. Ruiz-Gómez, T.A. Hill, S.Y. Chow, N.E. Shepherd, and R.J. Lohman Novel helix-constrained nociceptin derivatives are potent agonists and antagonists of ERK phosphorylation and thermal analgesia in mice J. Med. Chem. 53 23 2010 8400 8408
39. M. Rodríguez-Muñoz, E. de la Torre-Madrid, P. Sánchez-Blázquez, and J. Garzón Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins Mol. Pain. 3 2007 19
40. M. Rodríguez-Muñoz, P. Sánchez-Blázquez, A. Vicente-Sánchez, E. Berrocoso, and J. Garzón The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control Neuropsychopharmacology 37 2 2012 338 349
41. S. Merighi, S. Gessi, K. Varani, D. Fazzi, A. Stefanelli, and P.A. Borea Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKC-Akt-ERK1/2 signaling pathway in activated microglial cells Biochem. Pharmacol. 86 4 2013 487 496
42. M. Connor, P.B. Osborne, and M.J. Christie Mu-opioid receptor desensitization: is morphine different? Br. J. Pharmacol. 143 6 2004 685 696